# Nebraska Center for Nanomedicine

> **NIH NIH P30** · UNIVERSITY OF NEBRASKA MEDICAL CENTER · 2022 · $1,143,750

## Abstract

ABSTRACT
The multidisciplinary Nebraska Center for Nanomedicine (NCN), established in 2008 with the Center for
Biomedical Research Excellence (COBRE) funding, is building a nationally and internationally recognized
program of excellence in nanomedicine that combines broad expertise in material, pharmaceutical and
biological sciences driven by innovative research. NCN has completed its original objectives and enhanced
Nebraska's biomedical research capacity by creating a strategically linked infrastructure of strong research
programs and by mentoring a cadre of talented junior faculty to independent success. In the first 9 years of
funding, the NCN-funded junior faculty members obtained over $18 million in new research funds, eight NCN
trainees have been tenured and/or promoted, eight new junior and senior faculty with expertise relevant to
NCN were recruited to the College of Pharmacy. Our graduates have been appointed to editorial boards, serve
on review panels, and have countless invitations to present seminars. This NCN COBRE continuation proposal
details our plan to maintain a biomedical research center of national prominence and international recognition.
The specific aims that move the NCN toward these goals are: 1) continue to expand existing research
strengths through the support of collaborative interdisciplinary research and mentorship of junior faculty; 2)
strengthen research capabilities, innovation and funding support for investigators affiliated with the NCN; 3)
assure sustainability of scientific core facilities that are essential for the continued growth of the Center and
serve the research community at large. The realization of these aims will allow the NCN to emerge from Phase
III funding as self-sustaining center of research excellence in nanomedicine, with an increased capacity to
pursue programmatic support through individual and multi-investigator, program-wide research grants.
Through the development and clinical translation of effective nanomedicines for diagnosis and therapy for
human diseases, the NCN will ultimately provide significant benefits for the health of Nebraskans and society
at large.

## Key facts

- **NIH application ID:** 10441205
- **Project number:** 5P30GM127200-05
- **Recipient organization:** UNIVERSITY OF NEBRASKA MEDICAL CENTER
- **Principal Investigator:** David Oupicky
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,143,750
- **Award type:** 5
- **Project period:** 2018-06-01 → 2023-10-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10441205

## Citation

> US National Institutes of Health, RePORTER application 10441205, Nebraska Center for Nanomedicine (5P30GM127200-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10441205. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*